FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L, Luo L, Zhu H, Yang H, Zhang Y, Wu H, Sun H, Jiang F, Kathera CS, Liu L, Zhuang Z, Chen H, Pan F, Hu Z, Zhang J, Guo Z.
He L, et al. Among authors: hu z.
Mol Oncol. 2017 Sep;11(9):1302-1303. doi: 10.1002/1878-0261.12118.
Mol Oncol. 2017.
PMID: 28861953
Free PMC article.
No abstract available.